MALIGNANT DIGESTIVE SYSTEM NEOPLASM
Clinical trials for MALIGNANT DIGESTIVE SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT DIGESTIVE SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT DIGESTIVE SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stent study aims to improve blood flow and quality of life in GI cancer patients
Disease control Recruiting nowThis study is collecting information on the safety and effectiveness of placing a stent in the portal vein of people with gastrointestinal cancer who have a narrowed vein. The goal is to see how long the stent keeps the vein open and how it affects patients' overall well-being, i…
Matched conditions: MALIGNANT DIGESTIVE SYSTEM NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
Seaweed extract tested as chemo fatigue fighter
Symptom relief Recruiting nowThis study tests whether fucoidan, a supplement from brown seaweed, can reduce fatigue caused by chemotherapy. About 34 adults with gastrointestinal or gynecological cancer will take either fucoidan or a placebo daily for 16 weeks. Researchers will track fatigue levels using a si…
Matched conditions: MALIGNANT DIGESTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC
-
New algorithm aims to keep chemo on schedule for GI cancer patients
Symptom relief Recruiting nowThis study tests a tool called PAGODA that helps doctors adjust chemotherapy doses to avoid unplanned treatment delays. About 420 people with gastrointestinal cancers will be randomly assigned to use the algorithm or receive usual care. The goal is to see if the algorithm reduces…
Matched conditions: MALIGNANT DIGESTIVE SYSTEM NEOPLASM
Phase: NA • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Jun 15, 2026 18:54 UTC
-
Could a slower chemotherapy infusion save patients from nerve pain?
Symptom relief Recruiting nowThis study looks at whether giving the chemotherapy drug oxaliplatin over 6 hours instead of the usual 2 hours can prevent or delay nerve damage in people with gastrointestinal cancers. About 60 participants will be assigned to one of the two infusion times. The goal is to see if…
Matched conditions: MALIGNANT DIGESTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 10, 2026 13:28 UTC
-
Massive study tracks proton therapy side effects to predict future risks
Knowledge-focused Recruiting nowThis study gathers information on side effects from proton therapy in 5,000 adults with various cancers. Researchers will collect details on treatment plans and any short- or long-term side effects. The goal is to better predict who might have side effects and improve future care…
Matched conditions: MALIGNANT DIGESTIVE SYSTEM NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC
-
Scientists hunt for clues behind biliary tree cancers
Knowledge-focused Recruiting nowThis study looks at what causes biliary tree cancers by examining environmental, viral, and genetic factors. Researchers will study 1,500 people, including patients and healthy volunteers, to find markers that predict cancer development and treatment response. The goal is to help…
Matched conditions: MALIGNANT DIGESTIVE SYSTEM NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 11, 2026 11:57 UTC
-
Can a simple test predict Chemo-Related heart risks?
Knowledge-focused Recruiting nowThis study looks at how chemotherapy drugs like 5-FU and capecitabine affect blood vessels in people with gastrointestinal cancer. Researchers will use a device called EndoPAT to measure blood vessel function before, during, and after treatment. Some participants will also receiv…
Matched conditions: MALIGNANT DIGESTIVE SYSTEM NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:08 UTC
-
Are surgeons following guidelines to prevent deadly clots after cancer surgery?
Knowledge-focused Recruiting nowThis study surveys 500 surgeons and advanced practice providers to see how often they prescribe blood clot prevention medication after abdominal or pelvic cancer surgery. The goal is to understand current practices and improve adherence to guidelines. No patients are treated dire…
Matched conditions: MALIGNANT DIGESTIVE SYSTEM NEOPLASM
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:17 UTC